NWF Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$245K Sell
1,640
-197
-11% -$27.6K 0.02% 350
2026
Q2
$232K Buy
1,837
+3
+0.2% +$395 0.02% 366
2026
Q1
$256K Buy
1,834
+1
+0.1% +$140 0.03% 321
2025
Q4
$225K Buy
+1,833
New +$223K 0.02% 338
2025
Q3
– Sell
-2,162
Closed -$240K – 432
2025
Q2
$240K Buy
2,162
+299
+16% +$31.8K 0.03% 337
2025
Q1
$209K Sell
1,863
-372
-17% -$38.4K 0.03% 318
2024
Q4
$206K Buy
+2,235
New +$201K 0.03% 253

Other funds holding GILD

NWF Advisory Services's GILD Position: Q3 2026 in Review

NWF Advisory Services reduced its Gilead Sciences (GILD) stake by 11% in Q3 2026, selling an estimated $27.6K and leaving 1,640 shares worth $245K. The position accounts for 0.02% of the portfolio, ranked #350.

NWF Advisory Services first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $256K in Q1 2026. 2,318 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • NWF Advisory Services held 1,640 shares of Gilead Sciences worth $245K as of Q3 2026.
  • NWF Advisory Services sold 197 Gilead Sciences shares in Q3 2026, an estimated $27.6K.
  • Gilead Sciences made up 0.02% of NWF Advisory Services's portfolio in Q3 2026, its #350 holding.
  • NWF Advisory Services first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • NWF Advisory Services's Gilead Sciences position peaked at $256K in Q1 2026.
  • 2,318 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on NWF Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.